Tenapanor in the Treatment of Irritable Bowel Syndrome with Constipation: Discovery, Efficacy, and Role in Management
Clinical and Experimental Gastroenterology · 2023-06 · Volume 16 · 79-85
DOI: 10.2147/ceg.s384251 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Experimental Gastroenterology, 2023-06. Verfasst von Anam Herekar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Augusta University, Augusta, GA, USA. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Augusta University, Augusta, GA, USA.
ORCID-Profile: Tennekoon Buddhika Karunaratne, Amol Sharma
Zitieren
APA
Herekar, A., Shimoga, D., Jehangir, A., Shahsavari, D., Yan, Y., Karunaratne, T. B., & Sharma, A. (2023). Tenapanor in the Treatment of Irritable Bowel Syndrome with Constipation: Discovery, Efficacy, and Role in Management. Clinical and Experimental Gastroenterology, Volume 16, 79-85. https://doi.org/10.2147/ceg.s384251
Vancouver
Herekar A, Shimoga D, Jehangir A, Shahsavari D, Yan Y, Karunaratne TB, et al. Tenapanor in the Treatment of Irritable Bowel Syndrome with Constipation: Discovery, Efficacy, and Role in Management. Clinical and Experimental Gastroenterology. 2023;Volume 16:79-85. doi:10.2147/ceg.s384251
BibTeX
@article{Herekar2023,
author = {Herekar, Anam and Shimoga, Dhanush and Jehangir, Asad and Shahsavari, Dariush and Yan, Yun and Karunaratne, Tennekoon Buddhika and Sharma, Amol},
title = {Tenapanor in the Treatment of Irritable Bowel Syndrome with Constipation: Discovery, Efficacy, and Role in Management},
journal = {Clinical and Experimental Gastroenterology},
year = {2023},
volume = {Volume 16},
pages = {79--85},
doi = {10.2147/ceg.s384251}
}
EUVIMED